These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28165798)

  • 1. Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.
    Guo Y; Zhong T; Duan XC; Zhang S; Yao X; Yin YF; Huang D; Ren W; Zhang Q; Zhang X
    Drug Deliv; 2017 Nov; 24(1):270-277. PubMed ID: 28165798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.
    Li ZY; Yin YF; Guo Y; Li H; Xu MQ; Liu M; Wang JR; Feng ZH; Duan XC; Zhang S; Zhang SQ; Wang GX; Liao A; Wang SM; Zhang X
    Int J Nanomedicine; 2020; 15():1809-1821. PubMed ID: 32214813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of poly (butadiene-block-ethylene oxide) based amphiphilic polymersomes: An approach for improved oral pharmacokinetics of Sorafenib.
    Khan MA; Ali S; Venkatraman SS; Sohail MF; Ovais M; Raza A
    Int J Pharm; 2018 May; 542(1-2):196-204. PubMed ID: 29551745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Solubility and Oral Bioavailability of Febuxostat by Polymer-Coated Nanomatrix.
    Yin YF; Guo Y; Song WD; Duan XC; Zheng XC; Zhong T; Zhang S; Yao X; Xu MQ; Zhang Q; Zhang X
    AAPS PharmSciTech; 2018 Feb; 19(2):934-940. PubMed ID: 29079988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy.
    Wang Y; Molin DG; Sevrin C; Grandfils C; van den Akker NM; Gagliardi M; Knetsch ML; Delhaas T; Koole LH
    Int J Pharm; 2016 Apr; 503(1-2):150-62. PubMed ID: 26965198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
    Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
    Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.
    Cervello M; Pitarresi G; Volpe AB; Porsio B; Balasus D; Emma MR; Azzolina A; Puleio R; Loria GR; Puleo S; Giammona G
    J Control Release; 2017 Nov; 266():47-56. PubMed ID: 28917533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
    Tang X; Chen L; Li A; Cai S; Zhang Y; Liu X; Jiang Z; Liu X; Liang Y; Ma D
    Drug Deliv; 2018 Nov; 25(1):1484-1494. PubMed ID: 29916268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Oral Bioavailability of Sorafenib by Optimizing the "Spring" and "Parachute" Based on Molecular Interaction Mechanisms.
    Liu C; Chen Z; Chen Y; Lu J; Li Y; Wang S; Wu G; Qian F
    Mol Pharm; 2016 Feb; 13(2):599-608. PubMed ID: 26709621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and structure of drug-carrying biodegradable microspheres designed for transarterial chemoembolization therapy.
    Wang Y; Benzina A; Molin DG; Akker Nv; Gagliardi M; Koole LH
    J Biomater Sci Polym Ed; 2015; 26(2):77-91. PubMed ID: 25425276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma.
    Cao H; Wang Y; He X; Zhang Z; Yin Q; Chen Y; Yu H; Huang Y; Chen L; Xu M; Gu W; Li Y
    Mol Pharm; 2015 Mar; 12(3):922-31. PubMed ID: 25622075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
    Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
    Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer.
    Zhang Z; Niu B; Chen J; He X; Bao X; Zhu J; Yu H; Li Y
    Biomaterials; 2014 May; 35(15):4565-72. PubMed ID: 24602567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.
    Elzeny H; Zhang F; Ali EN; Fathi HA; Zhang S; Li R; El-Mokhtar MA; Hamad MA; Wooley KL; Elsabahy M
    Drug Des Devel Ther; 2017; 11():483-496. PubMed ID: 28260861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticles.
    Zhao ZB; Long J; Zhao YY; Yang JB; Jiang W; Liu QZ; Yan K; Li L; Wang YC; Lian ZX
    Biomater Sci; 2018 Mar; 6(4):893-900. PubMed ID: 29512660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
    Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
    Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of redox-responsive sorafenib carrier nanomicelles synthesized from poly (acryic acid) -cystamine hydrochloride-D-α-tocopherol succinate.
    Liu Y; Yang J; Wang X; Liu J; Wang Z; Liu H; Chen L
    J Biomater Sci Polym Ed; 2016 Dec; 27(17):1729-1747. PubMed ID: 27632696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat.
    Wang XQ; Fan JM; Liu YO; Zhao B; Jia ZR; Zhang Q
    Int J Pharm; 2011 Oct; 419(1-2):339-46. PubMed ID: 21843612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
    Li YJ; Dong M; Kong FM; Zhou JP
    Int J Pharm; 2015 Jul; 489(1-2):83-90. PubMed ID: 25888801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.
    Sui J; Cui Y; Cai H; Bian S; Xu Z; Zhou L; Sun Y; Liang J; Fan Y; Zhang X
    Nanoscale; 2017 Feb; 9(8):2755-2767. PubMed ID: 28155940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.